coronavirus
#Valneva expects to agree full UK joint investment for possible #COVID vaccine in weeks: CFO
Valneva said on Wednesday (5 August) Britain was committing an initial investment of more than £10 million ($13.12m) to increase production capacity for a possible COVID-19 vaccine, and that it expected negotiations on a full package to be agreed in weeks, writes Richard Lough.
“We are in the detailed work to finalize the agreement,” Valneva CFO David Lawrence told Reuters.
Lawrence said Valneva planned to supply 60 million doses of an eventual vaccine to Britain in the second half of 2021.
Share this article:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
-
Health4 days agoCounterfeit cigarettes drive illicit tobacco trade to highest level in a decade, new study claims
-
Libya4 days agoLibya’s fuel crisis offers lessons for energy security on both sides of the Mediterranean
-
Law4 days agoEU Cybersecurity Act could expose member states to costly investment treaty claims, legal opinion warns
-
European Commission4 days agoSpring semester package: Steering EU economies to increased competitiveness
